Eli Lilly Clinical Trials

Clinical trials sponsored by Eli Lilly — phases, conditions and reported results. Data from ClinicalTrials.gov.

• A Study of Baricitinib (LY3009104) in Children and Adolescents With Atopic Dermatitis
  Phase 3 · Atopic Dermatitis · Completed · Jun 29, 2023
• Clinical Trial of Solanezumab for Older Individuals Who May be at Risk for Memory Loss
  Phase 3 · Cognition Disorders · Completed · Dec 28, 2023
• A Study of LY3556050 in Adult Participants With Diabetic Peripheral Neuropathic Pain
  Phase 2 · Diabetic Peripheral Neuropathy · Completed · Jul 30, 2026
• A Study of Imlunestrant, Investigator's Choice of Endocrine Therapy, and Imlunestrant Plus Abemaciclib in Part
  Phase 3 · Breast Neoplasms · Active, not recruiting · Jul 11, 2025
• A Study of Ramucirumab (LY3009806) or Merestinib (LY2801653) in Advanced or Metastatic Biliary Tract Cancer
  Phase 2 · Biliary Tract Cancer · Active, not recruiting · Feb 26, 2021
• Study of Evorpacept (ALX148) With Cetuximab and Pembrolizumab for Refractory Microsatellite Stable Metastatic
  Phase 2 · Microsatellite Stable Metastatic Colorectal Cancer · Terminated · Jul 22, 2026
• A Study of Once-Daily Oral Orforglipron (LY3502970) in Japanese Adult Participants With Obesity Disease
  Phase 3 · Obesity · Completed · Jul 20, 2026
• A Study to Compare Tablets and Capsules of Orforglipron (LY3502970) in Healthy Participants Who Are Obese or O
  Phase 1 · Healthy · Completed · Jul 17, 2026
• A Study of LY3502970 in Chinese Participants With Obesity or Are Overweight With Weight-related Comorbidities
  Phase 1 · Overweight · Completed · Jul 17, 2026
• A Drug-Drug Interaction (DDI) Study of Orforglipron With Carbamazepine in Healthy Participants
  Phase 1 · Healthy · Completed · Jul 17, 2026
• A Study of LY3502970 in Japanese Participants With Type 2 Diabetes Mellitus
  Phase 1 · Diabetes Mellitus, Type 2 · Completed · Jul 16, 2026
• A Crossover Study to Evaluate Pegilodecakin (LY3500518) in Healthy Participants
  Phase 1 · Healthy Adult Subjects · Completed · Jul 13, 2026
• A Study of Baricitinib in Participants With Rheumatoid Arthritis
  Phase 4 · Rheumatoid Arthritis · Completed · Jul 10, 2026
• A Multiple Dose Study of LY3502970 in Healthy Overweight and Obese Participants
  Phase 1 · Healthy · Completed · Jul 10, 2026
• A Study of LY3502970 in Healthy Participants
  Phase 1 · Healthy · Completed · Jul 10, 2026

Trials by company

PfizerMerck (MSD)RocheNovartisAstraZenecaJohnson & Johnson (Janssen)Bristol Myers SquibbSanofiGSKEli LillyAbbVieAmgenBayerBoehringer IngelheimNovo NordiskTakedaGilead SciencesModernaBioNTechRegeneronVertexBiogenDaiichi SankyoAstellas PharmaEisaiOtsukaServierIncyteCelltrionSamsung BioepisHanmi PharmaceuticalYuhan

All trials